Synergistic combinations of signaling pathway inhibitors: Mechanisms for improved cancer therapy
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology
Reference115 articles.
1. Rapid turnover of mcl-1 couples translation to cell survival and apoptosis;Adams;J. Biol. Chem.,2007
2. The RSK family of kinases: emerging roles in cellular signalling;Anjum;Nat. Rev. Mol. Cell Biol.,2008
3. Targeted therapies in gastrointestinal stromal tumors;Antonescu;Semin. Diagn. Pathol.,2008
4. HER3 and mutant EGFR meet MET;Arteaga;Nat. Med.,2007
5. Synergic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitors on pancreatic cancer cells;Azzariti;Biochem. Pharmacol.,2008
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Iodoquinazoline-derived VEGFR-2 and EGFRT790M dual inhibitors: Design, synthesis, molecular docking and anticancer evaluations;Bioorganic Chemistry;2024-02
2. New quinazoline sulfonamide derivatives as potential anticancer agents: Identifying a promising hit with dual EGFR/VEGFR-2 inhibitory and radiosensitizing activity;Bioorganic Chemistry;2023-11
3. Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer;Frontiers in Pharmacology;2023-09-15
4. Fam72a functions as a cell-cycle-controlled gene during proliferation and antagonizes apoptosis through reprogramming PP2A substrates;Developmental Cell;2023-03
5. Design, synthesis, docking, ADMET and anticancer evaluations of N-alkyl substituted iodoquinazoline derivatives as dual VEGFR-2 and EGFR inhibitors;RSC Advances;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3